Shahjahan Molla

Shahjahan Molla

Auto-generated profile, based on publicly available information

Shahjahan Molla

Center for Engineered Cancer Testbeds North Dakota State University Fargo ND USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
TATayebeh Anajafi
Tayebeh Anajafi
JYJunru Yu
Junru Yu
ASAbbas Sedigh
Abbas Sedigh
MHManas K. Haldar
Manas K. Haldar
WMWallace W. Muhonen
Wallace W. Muhonen
SMSanku Mallik
Sanku Mallik

22 November 2018 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
SKSumanta Kar
Sumanta Kar
SMShahjahan Molla
Shahjahan Molla
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
KKKalpana S Katti
Kalpana S Katti
Breast cancer (BrCa) preferentially spreads to bone and colonizes within the bone marrow to cause bone metastases. To improve the outcome of patients with breast cancer bone metastasis, we need to understand better the mechanisms underlying bone metastasis. Researchers have relied heavily upon in vivo xenografts due to limited availibility of human bone metastasis samples. A significant limitation of these is that they do not have a human bone microenvironment. To address this issue, we have developed a nanoclay based 3D in vitro model of breast cancer bone metastasis using human breast cancer cells mimicking late stage of breast cancer pathogenesis at the metastatic site. This 3D model can provide a microenvironment suitable for cell‐cell, and cell‐matrix interactions while retaining the behavior of BrCa cells with different metastasis potential (i.e., highly metastatic MDA‐MB‐231, and low metastatic MCF‐7) as shown by the production of alkaline phosphatase (ALP) and matrix metalloproteinase‐9 (MMP‐9). The sequential culture of mesenchymal stem cells (MSCs) with MCF‐7 exhibited 3D tumoroids formation and also occurrence of mesenchymal to epithelial transition of cancer metastasis as evidenced by gene expression and immunocytochemistry. The unique and distinct behavior of highly metastatic MDA‐MB‐231 and the low metastatic MCF‐7 was observed at the bone metastasis site. The changes to migratory capabilities and invasiveness in MDA‐MB‐231 in comparison to tumor growth with MCF‐7 was observed. Together, a novel bone‐mimetic 3D in vitro breast cancer model has been developed that could be used to study mechanisms governing the later stage of cancer pathogenesis in bone.

4 October 2017 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
SMShahjahan Molla
Shahjahan Molla
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
KKKalpana S Katti
Kalpana S Katti

1 December 2017 in Journal of Nanomechanics and Micromechanics
Verified
Journal Article
Closed access
ASAnurag Sharma
Anurag Sharma
SMShahjahan Molla
Shahjahan Molla
KKKalpana S Katti
Kalpana S Katti
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
Biomaterials selection and design, and mechanical properties evolution during degradation and tissue regeneration play a critical role in the successful design of nanocomposite scaffolds for bone tissue regeneration. A new multiscale mechanics-based in silico approach is developed to provide a robust predictive methodology for nanocomposite scaffolds. Scaffolds are fabricated using amino acid–modified nanoclay with biomineralized hydroxyapatite (in situ HAPclay) and polycaprolactone (PCL). Steered molecular dynamics (SMD) simulations of the molecular models of HAPclay and the PCL composite provide a mechanical response of the material and the nature of the molecular interactions among constituents. The mechanical responses obtained from SMD are incorporated into a finite element (FE) model of a PCL/in situ HAPclay scaffold with its microstructure obtained from microcomputed tomography images. The model is validated using experimental results. The stress–strain response from multiscale models and experiments shows good agreement with the consideration of wall porosity correction. The multiscale models incorporate damage mechanics–based degradation and healing behavior to capture the evolution of the mechanical properties as the scaffolds degrade and human osteoblasts grow and proliferate inside the scaffolds. The novel multiscale models provide a robust prediction of the mechanical properties evolution in the scaffolds over the time evolution of cell growth proliferation and tissue formation.

19 November 2019 in JBMR Plus
Verified
Journal Article
Open access
PDF file
SMShahjahan Molla
Shahjahan Molla
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
JIJairam Iswara
Jairam Iswara
RVRenugopalakrishnan Venkatesan
Renugopalakrishnan Venkatesan
RPRamasamy Paulmurugan
Ramasamy Paulmurugan
KKKalpana S Katti
Kalpana S Katti
In this study, two types of prostate cancer cell lines, highly metastatic PC‐3 and low metastatic MDA PCa 2b (PCa) were cultured on bone mimetic scaffolds to recapitulate metastasis to bone. A unique in vitro 3D tumor model that uses a sequential culture (SC) of human mesenchymal stem cells followed by seeding with cancer cells after bone formation was initiated to study the phenotype‐specific interaction between prostate cancer cells and bone microenvironment. The PCa cells were observed to be less prolific and less metastatic, and to form multicellular tumoroids in the bone microenvironment, whereas PC‐3 cells were more prolific and were highly metastatic, and did not form multicellular tumoroids in the bone microenvironment. The metastatic process exhibited by these two prostate cancer cell lines showed a significant and different effect on bone mineralization and extracellular matrix formation. Excessive bone formation in the presence of PC‐3 and significant osteolysis in the presence of PCa were observed, which was also indicated by osteocalcin and MMP‐9 expression as measured by ELISA and qRT‐PCR. The field emission scanning electron microscopy images revealed that the structure of mineralized collagen in the presence of PC‐3 is different than the one observed in healthy bone. All experimental results indicated that both osteolytic and osteoblastic bone lesions can be recapitulated in our tumor testbed model and that different cancer phenotypes have a very different influence on bone at metastasis. The 3D in vitro model presented in this study provides an improved, reproducible, and controllable system that is a useful tool to elucidate osteotropism of prostate cancer cells. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

2 March 2016 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
KKKalpana S Katti
Kalpana S Katti
SMShahjahan Molla
Shahjahan Molla
FKFataneh Karandish
Fataneh Karandish
MHManas K. Haldar
Manas K. Haldar
SMSanku Mallik
Sanku Mallik
DKDinesh Ramanath Katti
Dinesh Ramanath Katti